- $13.46m
- $12.40m
- $19.48m
- 62
- 56
- 37
- 51
Annual balance sheet for cbdMD, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 15.1 | 27.4 | 7.72 | 1.8 | 2.45 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.911 | 1.11 | 1.45 | 1.22 | 0.984 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 23.7 | 36.5 | 16 | 8.07 | 6.39 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 10 | 8.18 | 5.3 | 4.07 | 0.54 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 111 | 125 | 40.8 | 16.2 | 10.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7.69 | 6.92 | 5.29 | 4.67 | 8.62 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 31.7 | 21.7 | 9.37 | 7.16 | 8.62 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 79.2 | 103 | 31.4 | 9.03 | 1.96 |
| Total Liabilities & Shareholders' Equity | 111 | 125 | 40.8 | 16.2 | 10.6 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |